SAN JOSE, September 6, 2023 /PRNewswire/ — Teikoku Pharma USA, a global pharmaceutical company, today announced positive results from its Phase 2 proof-of-concept study of TPU-006,…
SAN JOSE, September 6, 2023 /CNW/ — Teikoku Pharma USA, a global pharmaceutical company, today announced positive results from its Phase 2 proof-of-concept study of TPU-006,…
